Core Lab Swings to Q2 Loss Amid Revenue Dip
Ticker: CLB · Form: 10-Q · Filed: Jul 25, 2025 · CIK: 1958086
Sentiment: bearish
Topics: Oilfield Services, Energy Sector, Q2 Earnings, Net Loss, Revenue Decline, Debt Management, Interest Rate Swaps
Related Tickers: CLB, SLB, HAL, BKR
TL;DR
**Core Lab's Q2 loss is a red flag; sell before the oilfield services sector feels more pain.**
AI Summary
Core Laboratories Inc. (CLB) reported a net loss of $1.5 million for the second quarter of 2025, a significant decline from a net income of $3.2 million in the same period of 2024. Revenue for the second quarter of 2025 was $120.5 million, a slight decrease from $122.1 million in the second quarter of 2024. For the six months ended June 30, 2025, the company posted a net loss of $0.8 million, compared to a net income of $6.5 million in the prior year's comparable period. Total revenue for the six months ended June 30, 2025, was $240.1 million, down from $243.5 million in the first half of 2024. The Production Enhancement segment's revenue for the six months ended June 30, 2025, was $105.3 million, a decrease from $108.7 million in the prior year. The Reservoir Description segment's revenue for the same period was $134.8 million, down from $134.8 million. The company's strategic outlook includes managing its debt, with $100.0 million outstanding on its revolving credit facility as of June 30, 2025, and addressing interest rate swap liabilities which had a fair value of $(1.6) million at June 30, 2025.
Why It Matters
Core Laboratories' shift from profit to a net loss of $1.5 million in Q2 2025, coupled with a slight revenue decline, signals potential headwinds for investors in the oilfield services sector. This performance could impact employee morale and future hiring, while customers might see pricing adjustments or changes in service offerings. In a competitive landscape, this downturn could allow rivals to gain market share, especially if Core Lab's financial flexibility is constrained by its $100.0 million revolving credit facility debt. The broader market may interpret this as a sign of softening demand in certain segments of the energy industry.
Risk Assessment
Risk Level: high — The company reported a net loss of $1.5 million in Q2 2025, a significant deterioration from a $3.2 million net income in Q2 2024. This, combined with a $100.0 million outstanding on its revolving credit facility and a negative fair value of $(1.6) million for interest rate swaps, indicates financial strain and increased leverage risk.
Analyst Insight
Investors should consider reducing their exposure to CLB given the swing to a net loss and persistent revenue declines. Monitor upcoming earnings reports closely for any signs of stabilization or further deterioration in the company's financial health and debt management.
Financial Highlights
- debt To Equity
- N/A
- revenue
- $240.1M
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- N/A
- net Income
- -$0.8M
- eps
- N/A
- gross Margin
- N/A
- cash Position
- N/A
- revenue Growth
- -1.4%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Production Enhancement | $105.3M | -3.1% |
| Reservoir Description | $134.8M | 0.0% |
Key Numbers
- $1.5M — Net Loss (Q2 2025, a swing from $3.2M net income in Q2 2024)
- $120.5M — Q2 2025 Revenue (Slight decrease from $122.1M in Q2 2024)
- $0.8M — Six-Month Net Loss (For period ended June 30, 2025, compared to $6.5M net income in prior year)
- $240.1M — Six-Month Revenue (For period ended June 30, 2025, down from $243.5M in prior year)
- $100.0M — Revolving Credit Facility Debt (Outstanding as of June 30, 2025, indicating leverage)
- $(1.6)M — Interest Rate Swap Liability (Fair value at June 30, 2025, representing a financial obligation)
Key Players & Entities
- Core Laboratories Inc. /DE/ (company) — filer of the 10-Q
- Bloomberg (company) — publisher of the analysis
- $1.5 million (dollar_amount) — net loss for Q2 2025
- $3.2 million (dollar_amount) — net income for Q2 2024
- $120.5 million (dollar_amount) — revenue for Q2 2025
- $122.1 million (dollar_amount) — revenue for Q2 2024
- $0.8 million (dollar_amount) — net loss for six months ended June 30, 2025
- $6.5 million (dollar_amount) — net income for six months ended June 30, 2024
- $100.0 million (dollar_amount) — outstanding on revolving credit facility as of June 30, 2025
- $(1.6) million (dollar_amount) — fair value of interest rate swap liabilities at June 30, 2025
FAQ
What was Core Laboratories Inc.'s net income for Q2 2025?
Core Laboratories Inc. reported a net loss of $1.5 million for the second quarter of 2025, a significant decrease from a net income of $3.2 million in the same period of 2024.
How did Core Laboratories Inc.'s revenue change in Q2 2025 compared to Q2 2024?
Core Laboratories Inc.'s revenue for the second quarter of 2025 was $120.5 million, a slight decrease from $122.1 million reported in the second quarter of 2024.
What is the total revenue for Core Laboratories Inc. for the first six months of 2025?
For the six months ended June 30, 2025, Core Laboratories Inc. reported total revenue of $240.1 million, down from $243.5 million in the first half of 2024.
What was the net income for Core Laboratories Inc. for the first six months of 2025?
Core Laboratories Inc. posted a net loss of $0.8 million for the six months ended June 30, 2025, compared to a net income of $6.5 million in the prior year's comparable period.
How much debt does Core Laboratories Inc. have on its revolving credit facility?
As of June 30, 2025, Core Laboratories Inc. had $100.0 million outstanding on its revolving credit facility.
What is the fair value of Core Laboratories Inc.'s interest rate swap liabilities?
The fair value of Core Laboratories Inc.'s interest rate swap liabilities was $(1.6) million at June 30, 2025, indicating a net liability position.
How did the Production Enhancement segment perform for Core Laboratories Inc. in the first half of 2025?
The Production Enhancement segment's revenue for Core Laboratories Inc. for the six months ended June 30, 2025, was $105.3 million, a decrease from $108.7 million in the prior year.
What was the revenue for Core Laboratories Inc.'s Reservoir Description segment in the first half of 2025?
The Reservoir Description segment's revenue for Core Laboratories Inc. for the six months ended June 30, 2025, was $134.8 million, which was unchanged from $134.8 million in the prior year.
What are the key risks highlighted in Core Laboratories Inc.'s 10-Q filing?
Key risks include the swing to a net loss of $1.5 million in Q2 2025, the $100.0 million outstanding on the revolving credit facility, and the negative fair value of $(1.6) million for interest rate swaps, indicating financial strain and increased leverage.
What is the strategic outlook for Core Laboratories Inc. regarding its financial obligations?
Core Laboratories Inc.'s strategic outlook involves managing its debt, specifically the $100.0 million outstanding on its revolving credit facility, and addressing its interest rate swap liabilities which had a fair value of $(1.6) million at June 30, 2025.
Risk Factors
- Interest Rate Swap Liabilities [medium — financial]: The company has interest rate swap liabilities with a fair value of $(1.6) million as of June 30, 2025. Changes in market interest rates can adversely affect the fair value of these instruments and potentially impact future earnings.
- Revolving Credit Facility Usage [medium — financial]: As of June 30, 2025, Core Laboratories had $100.0 million outstanding on its revolving credit facility. Significant utilization of this facility indicates leverage and potential increased financial risk if market conditions deteriorate.
- Industry Downturn Impact [high — market]: The company's performance is closely tied to the oil and gas industry. A prolonged downturn or reduced capital spending by exploration and production companies can negatively impact demand for CLB's services and products.
- Dependence on Key Customers [medium — operational]: Core Laboratories may rely on a limited number of major customers for a significant portion of its revenue. The loss of one or more of these customers could have a material adverse effect on financial results.
- Environmental Regulations [low — regulatory]: The company operates in an industry subject to stringent environmental regulations. Changes in these regulations or increased compliance costs could impact operational expenses and profitability.
Industry Context
Core Laboratories operates within the oil and gas field services sector, providing specialized services and products to exploration and production companies. The industry is cyclical and highly dependent on global energy prices and capital expenditure by major oil companies. Competition is intense, with companies vying for contracts based on technological expertise, service quality, and cost-effectiveness.
Regulatory Implications
The company is subject to standard corporate regulations and reporting requirements for publicly traded companies in the U.S. Additionally, its operations in the energy sector may involve compliance with environmental regulations related to oil and gas extraction and processing, which could lead to increased operational costs or require specific permits.
What Investors Should Do
- Monitor Debt Levels
- Analyze Segment Performance
- Assess Profitability Turnaround
- Review Interest Rate Risk
Key Dates
- 2025-06-30: End of Second Quarter 2025 — Reporting period for the 10-Q filing, showing a net loss and decreased revenue compared to the prior year.
- 2025-07-25: Filing Date of 10-Q — Public disclosure of the company's financial performance and position for the period ended June 30, 2025.
- 2025-07-22: Subsequent Event - Minimum — Indicates events that occurred after the balance sheet date but before the filing date, which may require disclosure.
Glossary
- Production Enhancement
- An operating segment of Core Laboratories that likely focuses on services and products aimed at improving the output of oil and gas wells. (Key revenue-generating segment whose performance impacts overall company results.)
- Reservoir Description
- An operating segment of Core Laboratories that likely provides services and technologies for analyzing and characterizing oil and gas reservoirs. (Another key revenue-generating segment; its performance is crucial for the company's financial health.)
- Revolving Credit Facility
- A type of credit facility that allows a company to borrow, repay, and re-borrow funds up to a certain limit over a specified period. (Indicates the company's access to liquidity and its current leverage, with $100.0 million drawn as of June 30, 2025.)
- Interest Rate Swap
- A derivative contract where two parties exchange interest rate payments, typically to manage exposure to interest rate fluctuations. (Represents a financial obligation or asset whose fair value can impact earnings, with a liability of $(1.6) million at June 30, 2025.)
- Fair Value
- The price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. (Used to value financial instruments like interest rate swaps, indicating their market-based worth.)
Year-Over-Year Comparison
Compared to the prior year's comparable period, Core Laboratories Inc. has experienced a significant downturn. For the six months ended June 30, 2025, the company reported a net loss of $0.8 million, a stark contrast to a net income of $6.5 million in the first half of 2024. Total revenue also saw a slight decrease, falling from $243.5 million to $240.1 million. While the Reservoir Description segment remained flat, the Production Enhancement segment experienced a revenue decline, contributing to the overall weaker financial performance.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on July 25, 2025 regarding Core Laboratories Inc. /DE/ (CLB).